High risk of infectious disease caused by salmonellae and mycobacteria infections in patients with Crohn disease treated with anti-interleukin-12 antibody.
Fieschi
Claire
C
Allez
Matthieu
M
Casanova
Jean-Laurent
JL
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D018664:Interleukin-12 / Q000276:immunology*; D053762:Interleukin-12 Subunit p40; D009164:Mycobacterium Infections / Q000150:complications*; D021122:Protein Subunits / Q000276:immunology*; D012480:Salmonella Infections / Q000150:complications*
D000911:Antibodies, Monoclonal; D053762:Interleukin-12 Subunit p40; D021122:Protein Subunits; D018664:Interleukin-12